Conclusions -These immunohistochemical studies have shown the presence of Background -Epstein-Barr virus (EBV) EBV LMP1 protein in airway epithelial genome has been demonstrated in lung cells and overexpression of the cellular bcltissues of patients with lymphocytic inter-2 protein in lymphoid cells of lung tissue stitial pneumonia (LIP) but its role in the in patients with LIP. These geographically pathogenesis of this condition is unclear.
tumour suppressor genes such as the p53 gene any possible contamination from carry-over.
Four sections from each block were used for destroy the normal tissue homeostasis by either promoting or inhibiting cell growth and pro-staining with the two monoclonal antibodies and with appropriate concentrations of nonliferation. In contrast, bcl-2 represents a distinct category of oncogenes by its effects on apoptosis specific IgG 1 (Sigma, St Louis, Missouri, USA) as negative controls. After dewaxing in xylene (programmed cell death).
11 It normally plays an important role in regulating apoptosis during the sections were transferred to silane coated slides and treated by boiling in 10 mM citric B cell development 8 and in the maintenance of B cell memory. 9 10 However, overexpression of acid (pH 6-6.3) to unmask antigenic sites. 16 The standard protocol for the alkaline phosbcl-2 has been associated with prolonged cell survival, which favours the acquisition of sec-phatase anti-alkaline phosphatase (APAAP) technique 17 was employed with the rabbit antiondary genetic events that could result in neoplasia 11 and production of low grade mouse immunoglobulin (Dakopatts, 1 in 20 dilution) serving as secondary antibody. The lymphoproliferative disorders such as LIP.
We have examined the expression of the EBV anti-LMP1 monoclonal antibody was diluted 1 in 50 as suggested by the suppliers while the latent membrane protein (LMP1) and that of the human bcl-2 oncoprotein because LMP1 anti-bcl-2 monoclonal antibody was diluted 1 in 400 as this concentration of the anti-bcl-2 has both an essential role in cell transformation 12 and can induce upregulation of bcl-monoclonal antibody facilitated detection of cells exhibiting high level expression of the bcl-2 in vitro. 13 14 Our objective was to determine whether the lungs of patients with LIP show 2 gene. All immunohistochemical staining was carried out in parallel with staining by nonupregulation of bcl-2 expression compared with the lungs of patients with the usual form of specific mouse IgG 1 at a concentration comparable to that of the test antibody. The speciinterstitial pneumonia (IPF) and normal lung tissue from patients who died without lung ficities of both the monoclonal antibodies were assessed by comparison of the test section with disease.
the corresponding control section stained with mouse IgG 1 . After completion of immunostaining the sections were counterstained with Methods   haematoxylin. The slides were coded prior to microscopic examination which was carried out Formalin fixed, paraffin embedded lung tissues were analysed from 13 patients with LIP col-without knowledge of the tissue source. The sensitivity of the anti-LMP1 monoclonal antilected from several sources, nine patients with IPF and from nine necropsy cases where death body was assessed by determining the percentage of positively stained cells in sections occurred from non-respiratory causes. The patients with LIP (mean (SD) age 56.1 (9.0) prepared from formalin fixed, paraffin embedded blocks of Namalwa cells. years) and those with IPF (mean (SD) age 59.7 (7.2) years) have been reported as part of an earlier study. 3 There were no serological data for EBV available on any of these patients. In   1     the LIP group five patients had concomitant  conditions that included AIDS (n=2), Sjö g-The total number of cells (n) stained by the ren's syndrome (n=2), and hypergamma-anti-LMP1 monoclonal antibody in each lung globulinaemia (n=1). The necropsy cases with section was counted using a hand held counter. normal lungs consisted of seven men and two The cross sectional area of each lung section women of mean (SD) age 64.0 (15.7) years was determined using the Bioquant BQ System and were obtained from the necropsy service IV software (R&M Biometrics Inc, Nashville, of the department of pathology at St Paul's Tennessee, USA). This software program conHospital. The causes of death in these cases tains a feature which integrates a measured included cardiac related illnesses (n=7), intra-circumferential distance to calculate the encerebral haemorrhage (n=1), and trauma (n= closed area. The cross sectional area (A) of the 1).
lung tissue section was obtained as the mean Formalin fixed, paraffin embedded tissue of the integrated areas from three measurefrom a case of nasopharyngeal carcinoma and ments of tissue outline. To correct for variation lymph node tissue from a case of follicular in cellularity in the different groups of specilymphoma served as positive tissue controls for mens the volume fraction of tissue component anti-LMP1 and anti-bcl-2 monoclonal anti-(f) was estimated by the method of point countbodies, respectively. In addition, Namalwa ing. 18 The LMP1 positivity, which is defined cells, a lymphoblastoid cell line containing two as the number of cells expressing LMP1 per copies of EBV per cell, 15 were included as a unit area of lung tissue, was calculated acpositive control for determining the sensitivity cording to the formula: of LMP1 immunostaining. LMP1 positivity= n f×A   Mouse monoclonal antibody against the EBV LMP1 (CS1-4) and human bcl-2 were pur-where n=the number of LMP1 positive cells, f=volume fraction of lung corresponding to chased from Dakopatts (Glostrup, Denmark). All specimens were cut into 5 m sections using tissue, and A=cross sectional area of the lung tissue. a fresh microtome blade for each block to avoid group.bmj.com on April 10, 2017 -Published by http://thorax.bmj.com/ Downloaded from domly selected fields simultaneously using a teaching microscope.
 
The prevalence of EBV among the three groups was analysed using contingency table analysis ( 2 statistics) with Tukey-type testing to correct for multiple comparisons. 20 Of the cases that were LMP1 positive, the data were transformed by logarithmic operation, analysed by the method of single factor analysis of variance ferroni procedure. 21 The mean cumulative scores for bcl-2 immunostaining were analysed using ANOVA. All calculations were done using Systat Version 6 (Evanston, Illinois, USA). The results were reported as the least squares estimates for the mean differences (with 95% CI) of LMP1 positivity and bcl-2 immunostaining between the groups.
Results

: -1
  LMP1 positive cells in the lung tissues from all three patient groups were of epithelial origin and were found primarily along bronchioles (fig 1a) . Diffuse LMP1 signals were localised in the apical region of these epithelial cells and were not observed in lymphoid cells in any of the patient samples. No immunostaining was observed in sections incubated with non- (fig 1b) .
control, (b) a patient with idiopathic pulmonary fibrosis (IPF), and (c) a patient with lymphocytic interstitial pneumonia (LIP). Positive bcl-2 immunostaining is observed in
The prevalence of EBV LMP1 in lung tissues immunostaining was observed in 10 out of 13 (77%) patients with LIP and three of nine (33%) cases in both control groups (pΖ0.05). LMP1 positivity (mean difference, 95% CI) of    -2  bcl-2 expression was assessed based on a histo-LIP cases was significantly greater than that of non-LIP cases: LIP versus IPF 2.39 (1.54 to logical semiquantitative grading system of bcl-2 immunostaining ranging from 0 (none) to 3 3.24); LIP versus necropsy controls 2.62 (1.77 to 3.47). There was no significant difference (high). Ten randomly selected fields from each slide were evaluated and the sum of scores in LMP1 positivity between the patients with IPF and the necropsy control group. In 5 m represented the cumulative score for that slide. To assess the reproducibility of the scoring sections prepared from formalin fixed, paraffin embedded Namalwa cells 78% of cells showed system the intra-observer and inter-observer variations were determined and expressed as positive immunostaining for LMP1 (data not presented). the coefficients of variation, R 2 /R 2max .
19 R 2 /R 2max values of [0.75 were considered to be acceptable. 19 The coefficient of intra-observer variation was established by the same observer :  --2   (PMK) scoring 100 randomly selected fields two months after the first scoring. The inter-In the lung tissue sections examined positive immunostaining for bcl-2 protein was restricted observer variation was determined by two individuals (PMK and RGH) scoring 100 ran-to cells of lymphoid origin (fig 2) . Figure 3 group.bmj.com on April 10, 2017 -Published by http://thorax.bmj.com/ Downloaded from any event the presence of LMP1 positive cells in the IPF and necropsy control groups in the current study is consistent with the serological evidence of EBV infection in the general population, 24 and the greater EBV density documented in lung tissue from LIP patients compared with the two control groups suggests that a more active EBV infection was present in LIP.
High levels of bcl-2 expression have been reported in a wide variety of lymphoproliferative disorders 6 7 and our study extends these reports by establishing that there is a high level of bcl-2 expression in LIP. Despite conflicting reports of whether the lymphocytic subpopulation in LIP is primarily of B or T by protecting against apoptosis. This extended cell survival could contribute to the increased number of lymphocytes observed in the tissue in LIP, and the increased opportunity for acshows the distribution of the cumulative scores for bcl-2 immunostaining in the lung sections quiring secondary defects in either growth factor or tumour suppressor genes 11 might account from the three groups of patients. The cumulative score for bcl-2 immunostaining (mean for the frequent progression of LIP to low or mid grade non-Hodgkin's lymphoma. difference, 95% CI) was significantly higher in the LIP group than in those with IPF or the Studies of EBV infected lymphoblastoid cell lines have suggested that LMP1 is directly necropsy control groups: 7.55 (7.18 to 7.92). There was no significant difference in the mean involved in upregulation of bcl-2 expression 13 25 in vitro, whereas the current study revealed cumulative scores between the IPF and necropsy control groups.
LMP1 and bcl-2 immunostaining within different cell types in lung tissue from patients The reproducibility of the bcl-2 scoring system was validated through the analysis of intra-with LIP. Replicative EBV infection with shedding of the virus from the cell surface usually observer and inter-observer coefficients of variation. The R 2 /R 2max value of intra-observer vari-occurs in epithelial cells and involves the expression of all of the approximately 80 genes ation on bcl-2 assessment was 0.97 and the inter-observer R 2 /R 2max value was 0.84. encoded by the virus. Infection and transformation of lymphocytes, on the other hand, results from organisation of the viral genome into a circular extrachromosomal episome that Discussion The results of this study show a greater pre-resides in the cell nucleus with expression of only about 10 viral genes 26 including LMP1. valence and density of EBV LMP1 and higher levels of bcl-2 expression in lung tissue from In contrast to other investigators (reviewed by Niedobitek et al 27 ) who have suggested that the patients with LIP than in those with IPF and non-diseased lungs. Previous studies have dem-lymphoid system is the site of EBV persistence in vivo, our observations clearly show evidence onstrated evidence of EBV genome in the lung of patients with LIP 2 3 and a virus-specific host of viral protein within lung epithelial cells. The expression of LMP1 in epithelial cells could immune response. 4 5 In addition, bronchoalveolar lavage studies 22 have suggested that therefore be serving as a marker for EBV infection of the lung, rather than as the direct the site of viral replication in the epithelial cells of the oropharynx could be extended to the cause of the increased bcl-2 expression by the infiltrating lymphocytes. Alternatively, the pauperipheral lung, and that the lung may serve as a reservoir for EBV replication. This concept city of LMP1 signals in lymphoid cells in lung tissue of patients with LIP could be explained was further supported by the observations of Egan et al 23 who reported a high prevalence of by the differences between cellular interactions in vitro and in vivo. 28 29 For example, LMP1 the EBV viral capsid antigen (VCA) and gp 340/220 glycoprotein in the lungs of patients expression can be demonstrated in cultured Namalwa cells that are derived from Burkitt's with IPF. The lower prevalence of EBV protein in the lungs of patients with IPF in the current lymphoma, whereas Western blotting of protein extracted from Burkitt's lymphoma cells obstudy may be related to differences in populations being examined and/or technical factors tained by biopsy does not reveal LMP1 protein. 28 Other groups have also observed no -for example, lung tissue processing, preservation of epitopes in lung tissue, differences direct correlation between LMP1 and bcl-2 expression in other lymphoproliferative in target epitopes (VCA and gp340/220 versus LMP1) -of immunohistochemical analysis. In disorders.
30 31 The absence of LMP1 staining 
